NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Product
October 5, 2011
With over 200 formulations already screened and fully compliant with 21 CFR Parts 170-199 (FDA) and/or Reg. (EU) No. 10/2011 (formerly Directive 2002/72/EC), Reg. (EC) No. 1935/2004, ten products NSF/ANSI 51 and 61 listed, LATI S.p.A. can cover the full product portfolio.
These preliminary certifications are often a good starting point for non critical healthcare applications. Cytotoxicity can be assessed upon request on selected products.